How much revenue does CannLabs make?

CannLabs reported $1.36 million in revenue for fiscal year 2014, up 353.8% from $300,734 in fiscal year 2013. In Q1 2015 revenue was $470,488.

What companies are similar to CannLabs?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Kali, Inc. (KALY), MultiCell Technologies, Inc. (MCET), Creative Edge Nutrition, Inc. (FITX), Nunzia Pharmaceutical Company (NUNZ).

CannLabs, Inc. (CANL) Stock

About CannLabs, Inc.

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consul...

At a glance

CannLabs reported revenue of $1.36 million for fiscal year 2014, up 353.8% from fiscal year 2013, and net income of -$1.61 million. In Q1 2015 (the quarter ended March 31, 2015) revenue was $470,488, up 319.1% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2014.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.